India has disrupted global supply of COVAX: USAID

In India, the supply of Covax (COVAX) is severely hampered by the ongoing crisis caused by Corona virus infection (COVID-19). In many parts of the world, health workers or frontline workers have received one dose of corona vaccine and the other dose is not known yet. This statement was given by the top official of Biden administration on Thursday to the MPs there. "The scale of the outbreak in India has impacted COVAX," said Samantha Power, administrator of USAID, the US agency for international development.

 In response to a question about the shortage of the vaccine, Power said, "The Serum Institute of India had decided to supply more than 140 million doses of the vaccine by the end of June but in view of the crisis in the country Had to change it. He said, "Now countries like ours are expected to contribute to the supply for COVAX."

This issue of the corona vaccine arose during the discussion about the 2022 budget for USAID. Power further said, 'The biggest issue at the moment is that in many parts of the world, so far, frontline workers, including health workers, have been given the same dose of vaccine and not getting the second dose because the vaccine supply from India is stopped. It has been given because the situation there is uncontrollable due to the epidemic there. ' He said, 'It is for us to see that all the health workers and frontline workers of the world can get the vaccine. I find that the biggest challenge facing COVAX so far is scarcity of funds, difficulty of supply. '